AI drug discovery platform raises Series B funding

Biotech investors cap off record year in fundraising

Exscientia Files For $100M IPO

Venture capitalists raise more than $100bn to target life sciences

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Reportable Launches Media Monitoring Service for Biotech, Medical Device and Pharmaceutical Companies

The Bright New Age of Venture Capital

Instadeep raises $100M for AI decision-making tools

Gartner: 75% of VCs will use AI to make investment decisions by 2025

UBS clients raise $650 mln for biggest yet biotech impact fund